Imbalance between interstitial collagenase and tissue inhibitor of metalloproteinases 1 in synoviocytes and fibroblasts upon direct contact with stimulated T lymphocytes: Involvement of membrane-associated cytokines

Arthritis and Rheumatism

Volumn 41, Issue 10, 1998, Pages 1748-1759

  Burger, Danielle ^a,c   Rezzonico, Roger ^a   Li, Jian Mei ^a   Modoux, Christine ^a   Pierce, Richard A ^b   Welgus, Howard G ^b   Dayer, Jean Michel ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b BARNES JEWISH HOSPITAL   (United States)

^c University Hospitals   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; INTERLEUKIN 1ALPHA; PROSTAGLANDIN E2; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL ACTIVATION; CELL INTERACTION; ENZYME SYNTHESIS; FIBROBLAST; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; REGULATORY MECHANISM; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; T LYMPHOCYTE;

ANTIBODY FORMATION; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; ANTIGENS, SURFACE; CELL COMMUNICATION; CELL LINE; COLLAGENASES; DINOPROSTONE; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-1; LYMPHOCYTE ACTIVATION; MACROPHAGE-1 ANTIGEN; MATRIX METALLOPROTEINASE 1; RNA, MESSENGER; SYNOVIAL MEMBRANE; T-LYMPHOCYTES; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSFORMING GROWTH FACTOR BETA;

EID: 0031689268     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199810)41:10<1748::AID-ART7>3.0.CO;2-3     Document Type: Article

References (56)

1. Krane SM, Goldring SR, Dayer J-M. Interactions among lymphocytes, monocytes and other synovial cells in rheumatoid synovium. In: Pick E, Landy M, editors. Lymphokines. Vol. 7. New York: Academic Press; 1982. p. 75-136.
2. Harris ED. Enzymes responsible for joint destruction. In: Harris ED, editor. Rheumatoid arthritis. Philadelphia: WB Saunders; 1997. p. 168-75.
3. Kleiner DE, Stetler-Stevenson WG. Structural biochemistry and activation of matrix metalloproteases. Curr Opin Cell Biol 1993; 5:891-7.
4. Murphy G, Willenbrock F. Tissue inhibitors of matrix metalloendopeptidases. Methods Enzymol 1995;248:496-510.
5. Dayer J-M, Arend WP. Cytokines and growth factors. In: Kelley WN, Harris ED Jr, Ruddy S, Sledge CB, editors. Textbook of rheumatology. Philadelphia: WB Saunders; 1997. p. 267-86.
6. Dayer J-M, Burger D. Interleukin-1, tumor necrosis factor and their specific inhibitors. Eur Cytokine Netw 1994;5:563-71.
7. Mauviel A. Cytokine regulation of metalloproteinase gene expression. J Cell Biochem 1993;53:288-95.
8. Wright JK, Cawston TE, Hazleman BL. Transforming growth factor β stimulates the production of the tissue inhibitor of metalloproteinases by human synovial and skin fibroblasts. Biochim Biophys Acta 1991;1094:207-10.
9. Lotz M, Guerne P-A. Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinases-1/erythroid potentiating activity (TIMP-1/EPA). J Biol Chem 1991;266:2017-20.
10. 3 induce on THP-1 cells distinct patterns of cell surface antigen expression, cytokine production, and responsiveness to contact with activated T cells. J Immunol 1992;149:2040-6.
11. Isler P, Vey E, Zhang JH, Dayer J-M. Cell surface glycoproteins expressed on activated human T-cells induce production of interleukin-1β by monocytic cells: a possible role of CD69. Eur Cytokine Netw 1993;4:15-23.
12. Lacraz S, Isler P, Vey E, Welgus HG, Dayer J-M. Direct contact between T lymphocytes and monocytes is a major pathway for induction of metalloproteinase expression. J Biol Chem 1994;269: 22027-33.
13. Miltenburg AMM, Lacraz S, Welgus HG, Dayer J-M. Immobilized anti-CD3 antibody activates T cell clones to induce the production of interstitial collagenase, but not tissue inhibitor of metalloproteinases, in monocytic THP-1 cells and dermal fibroblasts. J Immunol 1995;154:2655-67.
14. Li J-M, Isler P, Dayer J-M, Burger D. Contact-dependent stimulation of monocytic cells and neutrophils by stimulated human T-cell clones. Immunology 1995;84:571-6.
15. Zvaifler NJ, Boyle D, Firestein GS. Early synovitis - synoviocytes and mononuclear cells. Semin Arthritis Rheum 1994;23:11-6.
16. Georgopoulos S, Plows D, Kollias G. Transmembrane TNF is sufficient to induce localized tissue toxicity and chronic inflammatory arthritis in transgenic mice. J Inflamm 1996;46:86-97.
17. Akatsuka H, Okubo M, Ishida H, Chiba K, Imanishi K, Uchiyama T, et al. Synovial mononuclear cells consist of T cells which produce high levels of tumor necrosis factor α. Microbiol Immunol 1997;41:367-70.
18. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996;14:397-440.
19. Mackay F, Majeau GR, Hochman PS, Browning JL. Lymphotoxin β receptor triggering induces activation of the nuclear factor κB transcription factor in some cell types. J Biol Chem 1996;271: 24934-8.
20. Burger D, Chicheportiche R, Giri JG, Dayer J-M. The inhibitory effect of human interleukin-1 receptor antagonist is enhanced by type II interleukin-1 soluble receptor and hindered by type I interleukin-1 receptor. J Clin Invest 1995;96:38-41.
21. 2/collagenase production by human dermal fibroblasts and synovial cells. Immunobiology 1990;180:316-27.
22. Dayer J-M, Bréard J, Chess L, Krane SM. Participation of monocyte-macrophages and lymphocytes in the production of a factor that stimulates collagenase and prostaglandin release by rheumatoid synovial cells. J Clin Invest 1979;64:1386-92.
23. Gazdar AF, Carney DN, Bunn PA, Russell EK, Jaffe ES, Schechter GP, et al. Mitogen requirements for the in vitro propagation of T-cell lymphomas. Blood 1980;55:409-17.
24. Lou J, Dayer J-M, Grau GE, Burger D. Direct cell/cell contact with stimulated T lymphocytes induces the expression of cell adhesion molecules and cytokines by human brain microvascular endothelial cells. Eur J Immunol 1996;26:3107-13.
25. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
26. Vey E, Burger D, Dayer J-M. Expression and cleavage of tumor necrosis factor-α and tumor necrosis factor receptors by human monocytic cell lines upon direct contact with stimulated T cells. Eur J Immunol 1996;26:2404-9.
27. Pierce RA, Sandefur S, Doyle GAR, Welgus HG. Monocytic cell type-specific transcriptional induction of collagenase. J Clin Invest 1996;97:1890-9.
28. Krane SM, Conca W, Stephenson ML, Amento EP, Goldring MB. Mechanisms of matrix degradation in rheumatoid arthritis. Ann N Y Acad Sci 1985;460:340-54.
29. Kurosaka M, Ziff M. Immunoelectron microscopic study of the distribution of T cell subsets in rheumatoid synovium. J Exp Med 1983;158:1191-210.
30. Quayle A, Kjeldsen Kragh J, Førre Ø, Waalen K, Sioud M, Kalvenes C, et al. Immunoregulatory T cell subsets and T cell activation in rheumatoid arthritis: a need for analysis on the clonal and molecular level. Springer Semin Immunopathol 1989;11:273-87.
31. Sakata A, Sakata K, Ping H, Ohmura T, Tsukano M, Kakimoto K. Successful induction of severe destructive arthritis by the transfer of in vitro activated synovial fluid T cells from patients with rheumatoid arthritis in severe combined immunodeficient mice. Clin Exp Immunol 1996;104:247-54.
32. Mima T, Saeki Y, Ohshima S, Nishimoto N, Matsushita M, Shimizu M, et al. Transfer of rheumatoid arthritis into severe combined immunodeficient mice: the pathogenetic implications of T cell populations oligoclonally expanding in the rheumatoid joints. J Clin Invest 1995;96:1746-58.
33. Gravallese EM, Darling JM, Ladd AL, Katz JN, Glimcher LH. In situ hybridization studies of stromelysin and collagenase messenger RNA expression in rheumatoid synovium. Arthritis Rheum 1991;34:1076-84.
34. McCachren SS. Expression of metalloproteinases and metalloproteinase inhibitor in human arthritic synovium. Arthritis Rheum 1991;34:1085-93.
35. Woolley DE, Crossley MJ, Evanson JM. Collagenase at sites of cartilage erosion in the rheumatoid joint. Arthritis Rheum 1977; 20:1231-9.
36. Firestein GS, Paine MM, Boyle DL. Mechanisms of methotrexate action in rheumatoid arthritis: selective decrease in synovial collagenase gene expression. Arthritis Rheum 1994;37:193-200.
37. Firestein GS. Etiology and pathogenesis of rheumatoid arthritis. In: Kelley WN, Harris ED Jr, Ruddy S, Sledge CB, editors. Textbook of rheumatology. Philadelphia: WB Saunders; 1997. p. 851-97.
38. Brocker BM, Edwards JCW, Faqnger MW, Lydyard PM. The prevalence and distribution of macrophages bearing FcγR I, FcγR II, and FcγR III in synovium. Scand J Rheumatol 1990;19:123-35.
39. Burger D, Dayer J-M. Cell-cell interactions in chronic inflammation: modulation of surrounding cells by direct contact with stimulated T lymphocytes. In: Schneider CH, editor. Peptides in immunology. New York: John Wiley and Sons, Ltd.; 1996. p. 159-64.
40. 2 production by human synovial cells and dermal fibroblasts. J Exp Med 1985;162:2163-8.
41. 2 production by human synovial cells. J Clin Invest 1986;77:645-8.
42. Arend WP, Dayer J-M. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 1990;33:305-15.
43. McDonnell J, Hoerrner LA, Lark MW, Harper C, Dey T, Lobner J, et al. Recombinant human interleukin-1β-induced increase in levels of proteoglycans, stromelysin, and leukocytes in rabbit synovial fluid. Arthritis Rheum 1992;35:799-805.
44. Firestein GS. The immunopathogenesis of rheumatoid arthritis. Curr Opin Rheumatol 1991;3:398-406.
45. Keffer J, Probert L, Cazlaris H, Georgopoulos S, Kaslaris E, Kioussis D, et al. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J 1991;10:4025-31.
46. Probert L, Plows D, Kontogeorgos G, Kollias G. The type I interleukin-1 receptor acts in series with tumor necrosis factor (TNF) to induce arthritis in TNF-transgenic mice. Eur J Immunol 1995;25:1794-7.
47. Probert L, Akassoglou K, Alexopoulou L, Douni E, Haralambous S, Hill S, et al. Dissection of the pathologies induced by transmembrane and wild-type tumor necrosis factor in transgenic mice. J Leukoc Biol 1996;59:518-25.
48. Rankin EC, Choy EH, Kassimos D, Kingsley GH, Sopwith AM, Isenberg DA, et al. The therapeutic effects of an engineered human anti-tumour necrosis factor a antibody (CDP571) in rheumatoid arthritis. Br J Rheumatol 1995;34:334-42.
49. Feldmann M, Elliott MJ, Woody JN, Maini RN. Anti-tumor necrosis factor-α therapy of rheumatoid arthritis. Adv Immunol 1997;64:283-350.
50. Campion GV, Lebsack ME, Lookabaugh J, Gordon G, Catalano M, and the IL-Ra Arthritis Study Group. Dose-range and dose-frequency study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis. Arthritis Rheum 1996;39:1092-101.
51. Moreland LW, Heck LW Jr, Koopman WJ. Biologic agents for treating rheumatoid arthritis: concepts and progress. Arthritis Rheum 1997;40:397-409.
52. Fini ME, Strissel KJ, Girard MT, Mays JW, Rinehart WB. Interleukin-1α mediates collagenase synthesis stimulated by phorbol 12-myristate 13-acetate. J Biol Chem 1994;269:11291-8.
53. West Mays JA, Strissel KJ, Sadow PM, Fini ME. Competence for collagenase gene expression by tissue fibroblasts requires activation of an interleukin 1α autocrine loop. Proc Natl Acad Sci U S A 1995;92:6768-72.
54. Fries KM, Sempowski GD, Gaspari AA, Blieden T, Looney RJ, Phipps RP. CD40 expression by human fibroblasts. Clin Immunol Immunopathol 1995;77:42-51.
55. Yellin MJ, Winikoff S, Fortune SM, Baum D, Crow MK, Lederman S, et al. Ligation of CD40 on fibroblasts induces CD54 (ICAM-1) and CD106 (VCAM-1) up-regulation and IL-6 production and proliferation. J Leukoc Biol 1995;58:209-16.
56. Roy M, Waldschmidt T, Aruffo A, Ledbetter JA, Noelle RJ. The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells. J Immunol 1993;151:2497-510.